GlassScriptPhysician profile
Tiffany A Weakley
NPI 1730271412
$6,040.89
in general payments reported to CMS, 2019-2025
36 companies · $1,049 in 2025
The $1,049 reported for 2025 was more than what 85% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $843 · 2020: $275 · 2021: $896 · 2022: $946 · 2023: $1,122 · 2024: $910 · 2025: $1,049.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,080.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,080.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $1,176.42 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Astrazeneca Pharmaceuticals LP | $893.63 | 2019-2025 | Fasenra, Breztri, Tezspire |
| Glaxosmithkline, LLC. | $401.51 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $391.63 | 2019-2025 | Ofev, Jascayd, Stiolto Respimat |
| Takeda Pharmaceuticals U.S.A., INC. | $353.72 | 2021-2025 | Glassia |
| Regeneron Healthcare Solutions, INC. | $286.08 | 2021-2025 | Dupixent |
| United Therapeutics Corporation | $278.80 | 2021-2025 | Tyvaso, Tyvaso |
| Baxter Healthcare | $224.62 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Philips North America LLC | $183.65 | 2019-2025 | Vest Therapy Und |
| Mylan Specialty L.P. | $174.85 | 2019-2024 | Yupelri |
| Mallinckrodt Hospital Products INC. | $173.84 | 2022-2025 | Acthar |
| Electromed, INC. | $152.37 | 2022-2025 | Smartvest |
| Novartis Pharmaceuticals Corporation | $130.97 | 2019-2025 | |
| Insmed, INC. | $99.22 | 2019-2024 | Arikayce |
| Verona Pharma, INC. | $95.15 | 2025 | Ohtuvayre |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $94.48 | 2020-2024 | Prolastin-C Liquid |
| Advanced Respiratory, INC | $83.79 | 2019-2021 | |
| Novo Nordisk INC | $79.93 | 2021-2025 | Rybelsus, Ozempic |
| Sunovion Pharmaceuticals INC. | $75.54 | 2019-2020 | |
| Pfizer INC. | $72.32 | 2022-2023 | |
| Pulmonx Corporation | $69.21 | 2025 | Zephyr Endobronchial Valve, Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console |
| Merck Sharp & Dohme LLC | $60.88 | 2024-2025 | Winrevair |
| Jazz Pharmaceuticals INC. | $59.94 | 2019-2021 | |
| Mallinckrodt Enterprises LLC | $59.34 | 2019 | |
| Inogen, INC. | $49.87 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $48.56 | 2021-2022 | |
| Paratek Pharmaceuticals, INC. | $47.72 | 2022 | |
| Melinta Therapeutics, LLC | $42.91 | 2021 | |
| Genzyme Corporation | $35.93 | 2021 | |
| Ani Pharmaceuticals, INC. | $32.60 | 2023 | Purified Cortrophin Gel |
| Inspire Medical Systems, INC. | $25.94 | 2024 | Inspire |
| Shire North American Group INC | $23.20 | 2019 | |
| Vifor Pharma, INC. | $19.88 | 2025 | Zemaira |
| E.R. Squibb & Sons, L.L.C. | $15.07 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $14.08 | 2021 | |
| Esperion Therapeutics, INC. | $13.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tiffany Weakley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.